Home » Clinical Trials »  Search Clinical Trials

Therapeutic Areas:  |  Neurology  |  Family Medicine

Search Medical Condition
Please enter condition
Please choose location from dropdown

Alzheimer's Disease Clinical Trials

A listing of Alzheimer's Disease medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (567) clinical trials

To test the idea that solanezumab will slow the cognitive and functional decline of Alzheimer's Disease (AD) as compared with placebo in participants with mild AD.

Phase

The purpose of this study is to evaluate the effect of pioglitazone at 24 months compared with placebo on cognitive decline in high-risk participants who have completed the AD-4833/TOMM40_301 study [NCT01931566] with an adjudicated diagnosis of mild cognitive impairment (MCI) due to Alzheimer's Disease (AD).

Phase

The purpose of this study is to provide subjects who have completed participation in a Phase 2 or Phase 3 trial with TRx0237 continued access to therapy and to evaluate the long-term safety of TRx0237.

Phase

To establish efficacy of Lu AE58054 as adjunctive therapy to acetylcholinesterase inhibitors (AChEIs) for symptomatic treatment of patients with mild-moderate Alzheimer's disease (AD).

Phase

The primary objective of the study is to evaluate the efficacy of monthly doses of aducanumab in slowing cognitive and functional impairment as measured by changes in the Clinical Dementia Rating-Sum of Boxes (CDR-SB) score as compared with placebo in participants with early AD. Secondary objectives are to assess the ...

Phase

Research study of an investigational Alzheimer’s medication taken twice daily for people with early-stage Alzheimer’s Disease. In this research study, doctors want to test the safety and effectiveness of 4 different doses of the study drug and compare it to placebo in participants with early-stage Alzheimer’s Disease

Phase N/A

Research study of an investigational Alzheimer’s medication taken twice daily for people with mild Alzheimer's Disease. In this research study, doctors want to test the safety and effectiveness of 4 different doses of the study drug and compare it to donepezil and placebo in participants with Alzheimer’s Disease.

Phase N/A

The purpose of this trial is to assess the efficacy and safety of MK-8931 compared with placebo in the treatment of amnestic mild cognitive impairment (aMCI) due to Alzheimer's Disease (AD), also known as prodromal AD. Participants will be randomized to receive placebo, or 12 mg or 40 mg MK-8931, ...

Phase

This is an 18 month study in which subjects that screen and qualify will go onto the program taking the investigational medication by mouth once daily.

Phase N/A

California Neuroscience Research is conducting a research study on the effectiveness and safety of an investigational medication or placebo in patients with mild Alzheimer’s disease. The study has up to 31 office visits over up to 40 months. Participants will receive an investigational medication or placebo monthly by subcutaneous injection. ...

Phase N/A